Novartis Strengthens Cardiovascular Portfolio with $3.08 Billion Anthos Therapeutics Acquisition

Anthos Therapeutics, Inc., a business that produces abelacimab (full human monoclonal antibody), a late-stage medication being developed to prevent stroke and systemic embolism in patients with atrial fibrillation, has agreed to be acquired by Novartis. Upon concluding the deal, Novartis will pay $925 million upfront, subject to certain usual adjustments. If certain sales and regulatory milestones are met, Novartis may also pay an additional $2.15 billion.

Femasys Secures European Approval for FemBloc Delivery System, Paving the Way for the First Non-Surgical Permanent Birth Control

European women will soon be able to receive permanent birth control through a non-surgical approach. FemBloc, developed by Femasys, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, announces Conformité Européene (CE) mark certification under the European Union Medical Device Regulation (EU MDR) as the first regulatory approval in the world for the FemBloc® delivery system for non-surgical female permanent birth control.

Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs

Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle.

InSysBio announces its collaboration with discoveric bio alpha

The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid.

CariGenetics launches Caribbean Genome Programme with Oxford Nanopore to drive regional genomic research

CariGenetics and Oxford Nanopore Technologies have launched the Caribbean Genome Programme, the first large-scale genomic sequencing initiative in the region. This pioneering effort is set to address unmet need in advancing regional genetic research in the Caribbean, providing real-time, high throughput sequencing to address critical health disparities, starting with men’s health.

InformedDNA Acquires Coriell Life Sciences, Expanding Precision Health Capabilities

InformedDNA has acquired Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. The combination significantly expands patient, provider and payor access to a broader range of genetic insights and enables more personalized, data-driven treatment and medication decisions for better outcomes and reduced healthcare costs.

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking pathologist workforce.

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

START's site network solidifies its global leadership in urological cancer trials.

Sirio Launches Global Research Institute for Longevity Studies [SIA]

Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer

Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

This press release highlights the recent ruling by the United States District Court for the Central District of California, which denied QIAGEN’s Partial Motion to Dismiss and, in the alternative, to stay counterclaims brought by Zymo Research, including claims of patent unenforceability and antitrust violations.

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

Sapio Sciences today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery.

Coronado Research Announce the Appointment of Stephen Ralston as EVP Market Access and HEOR

Coronado Research, a consultancy-led, professional services organisation providing support to pharmaceutical, biotechnology, and medical device companies, has appointed Stephen Ralston as EVP Market Access and Health Economics Outcomes Research (HEOR).

Coronado Research Announce the Appointment of Nick Littlebury as EVP, Regulatory Affairs

Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle.

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

The press release highlights the Quick-16S™ Full-Length Library Prep Kit, which offers the fastest, most streamlined full-length 16S library preparation workflow. With as little as 30 minutes of hands-on time, the kit prepares 96 samples while ensuring high-quality libraries. The kit is optimized for both PacBio® SMRTbell® and Kinnex™ library prep kits, and is fully compatible with ONT® platforms, making it a versatile solution for diverse sequencing applications. Additionally, the integrated qPCR dye provides real-time quality control to guarantee the highest standards for every library.

From Reshaping Newborn Screening to Redefining Longevity Science, Bio-IT World 2025 Will Highlight Transformative Applications of New Technologies

Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of distinguished biotech, pharmaceutical, and healthcare leaders who are harnessing new technologies to push therapeutic boundaries.

ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks

ClearNote Health announced an agreement with Claritev, Inc., (previously MultiPlan, Inc.) that will make ClearNote Health’s Avantect Pancreatic Cancer Test available to health plan members accessing Claritev’s national PHCS and MultiPlan Networks.

Watson-Marlow Fluid Technology Solutions to showcase single-use advancements in sustainability and supply agility at INTERPHEX 2025

Watson-Marlow Fluid Technology Solutions(WMFTS) will reveal its new WMArchitect Interchangeable Parts service as well as showcase new sustainability benefits for its users from advancements in BioClamp manufacturing at booth 2753 during INTERPHEX 2025, held from April 1st-3rd at the Javits Center in NYC, USA.

Aragen appoints Dr. Manjunath Ramarao as Chief Scientific Officer and Executive Vice President, Integrated Drug Discovery; Jayadeva Sajankila as Vice President and Head, Chemical Development Solutions

Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare